Extendicare Inc. (EXETF)
USD 7.0
(-0.71%)
USD 7.0
(-0.71%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.3 Billion CAD | 6.83% |
| 2022 | 1.22 Billion CAD | 0.4% |
| 2021 | 1.21 Billion CAD | 5.05% |
| 2020 | 1.15 Billion CAD | 2.33% |
| 2019 | 1.13 Billion CAD | 1.07% |
| 2018 | 1.12 Billion CAD | 2.07% |
| 2017 | 1.09 Billion CAD | 3.45% |
| 2016 | 1.06 Billion CAD | 8.28% |
| 2015 | 979.6 Million CAD | 20.03% |
| 2014 | 816.11 Million CAD | -59.69% |
| 2013 | 2.02 Billion CAD | -0.64% |
| 2012 | 2.03 Billion CAD | -2.71% |
| 2011 | 2.09 Billion CAD | 1.21% |
| 2010 | 2.06 Billion CAD | -4.53% |
| 2009 | 2.16 Billion CAD | 4.98% |
| 2008 | 2.06 Billion CAD | 14.41% |
| 2007 | 1.8 Billion CAD | 3.38% |
| 2006 | 1.74 Billion CAD | -11.48% |
| 2005 | 1.97 Billion CAD | 12.88% |
| 2004 | 1.74 Billion CAD | 1.29% |
| 2003 | 1.72 Billion CAD | -1.77% |
| 2002 | 1.75 Billion CAD | 3.0% |
| 2001 | 1.7 Billion CAD | -5.69% |
| 2000 | 1.8 Billion CAD | -4.51% |
| 1999 | 1.89 Billion CAD | -10.42% |
| 1998 | 2.11 Billion CAD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 348.48 Million CAD | -5.07% |
| 2024 Q1 | 367.09 Million CAD | 4.83% |
| 2023 Q1 | 324.71 Million CAD | 4.61% |
| 2023 Q4 | 350.18 Million CAD | 8.57% |
| 2023 FY | 1.3 Billion CAD | 6.83% |
| 2023 Q3 | 322.52 Million CAD | 4.88% |
| 2023 Q2 | 307.53 Million CAD | -5.29% |
| 2022 Q1 | 305.71 Million CAD | 10.45% |
| 2022 Q4 | 310.39 Million CAD | 0.49% |
| 2022 Q2 | 296.58 Million CAD | -2.98% |
| 2022 Q3 | 308.88 Million CAD | 4.15% |
| 2022 FY | 1.22 Billion CAD | 0.4% |
| 2021 Q1 | 322.38 Million CAD | 4.76% |
| 2021 FY | 1.21 Billion CAD | 5.05% |
| 2021 Q2 | 307.44 Million CAD | -4.63% |
| 2021 Q4 | 276.79 Million CAD | -10.75% |
| 2021 Q3 | 310.13 Million CAD | 0.87% |
| 2020 Q3 | 296.78 Million CAD | 5.26% |
| 2020 Q4 | 307.74 Million CAD | 3.69% |
| 2020 Q2 | 281.94 Million CAD | 3.73% |
| 2020 Q1 | 271.81 Million CAD | -6.56% |
| 2020 FY | 1.15 Billion CAD | 2.33% |
| 2019 Q2 | 284.05 Million CAD | 3.57% |
| 2019 Q1 | 274.26 Million CAD | -5.03% |
| 2019 Q4 | 290.89 Million CAD | 2.89% |
| 2019 FY | 1.13 Billion CAD | 1.07% |
| 2019 Q3 | 282.73 Million CAD | -0.46% |
| 2018 Q1 | 271.42 Million CAD | -3.54% |
| 2018 FY | 1.12 Billion CAD | 2.07% |
| 2018 Q2 | 279.48 Million CAD | 2.97% |
| 2018 Q3 | 280.3 Million CAD | 0.29% |
| 2018 Q4 | 288.79 Million CAD | 3.03% |
| 2017 Q4 | 281.39 Million CAD | 2.99% |
| 2017 Q1 | 268.85 Million CAD | -2.89% |
| 2017 Q2 | 273.84 Million CAD | 1.85% |
| 2017 FY | 1.09 Billion CAD | 3.45% |
| 2017 Q3 | 273.23 Million CAD | -0.22% |
| 2016 FY | 1.06 Billion CAD | 8.28% |
| 2016 Q4 | 276.85 Million CAD | 3.27% |
| 2016 Q2 | 261.42 Million CAD | -0.38% |
| 2016 Q3 | 268.09 Million CAD | 2.55% |
| 2016 Q1 | 262.43 Million CAD | -3.11% |
| 2015 FY | 979.6 Million CAD | 20.03% |
| 2015 Q4 | 270.85 Million CAD | 2.85% |
| 2015 Q2 | 243.18 Million CAD | 20.26% |
| 2015 Q1 | 202.21 Million CAD | 125.93% |
| 2015 Q3 | 263.35 Million CAD | 8.29% |
| 2014 FY | 816.11 Million CAD | -59.69% |
| 2014 Q4 | -779.96 Million CAD | -245.46% |
| 2014 Q3 | 536.21 Million CAD | 0.86% |
| 2014 Q2 | 531.66 Million CAD | 0.66% |
| 2014 Q1 | 528.19 Million CAD | 1.7% |
| 2013 Q3 | 508.61 Million CAD | 2.02% |
| 2013 FY | 2.02 Billion CAD | -0.64% |
| 2013 Q4 | 519.37 Million CAD | 2.12% |
| 2013 Q2 | 498.52 Million CAD | 0.11% |
| 2013 Q1 | 497.95 Million CAD | 0.19% |
| 2012 Q4 | 497.03 Million CAD | -0.3% |
| 2012 Q2 | 524.68 Million CAD | 1.45% |
| 2012 FY | 2.03 Billion CAD | -2.71% |
| 2012 Q1 | 517.18 Million CAD | -1.08% |
| 2012 Q3 | 498.5 Million CAD | -4.99% |
| 2011 Q3 | 531.66 Million CAD | 2.24% |
| 2011 Q2 | 520.01 Million CAD | 0.09% |
| 2011 FY | 2.09 Billion CAD | 1.21% |
| 2011 Q4 | 522.85 Million CAD | -1.66% |
| 2011 Q1 | 519.54 Million CAD | -1.68% |
| 2010 Q4 | 528.39 Million CAD | 2.11% |
| 2010 Q1 | 508.83 Million CAD | -1.16% |
| 2010 FY | 2.06 Billion CAD | -4.53% |
| 2010 Q2 | 514.37 Million CAD | 1.09% |
| 2010 Q3 | 517.5 Million CAD | 0.61% |
| 2009 FY | 2.16 Billion CAD | 4.98% |
| 2009 Q1 | 584.24 Million CAD | 0.36% |
| 2009 Q2 | 563.14 Million CAD | -3.61% |
| 2009 Q3 | 532.13 Million CAD | -5.51% |
| 2009 Q4 | 514.82 Million CAD | -3.25% |
| 2008 Q1 | 491.55 Million CAD | 4.66% |
| 2008 FY | 2.06 Billion CAD | 14.41% |
| 2008 Q4 | 582.16 Million CAD | 14.83% |
| 2008 Q3 | 506.98 Million CAD | 1.82% |
| 2008 Q2 | 497.94 Million CAD | 1.3% |
| 2007 FY | 1.8 Billion CAD | 3.38% |
| 2007 Q3 | 434.02 Million CAD | -2.23% |
| 2007 Q4 | 469.67 Million CAD | 8.22% |
| 2007 Q2 | 443.9 Million CAD | -2.83% |
| 2007 Q1 | 456.84 Million CAD | 70.85% |
| 2006 Q2 | 489.83 Million CAD | 0.16% |
| 2006 Q4 | 267.38 Million CAD | -46.59% |
| 2006 Q1 | 489.04 Million CAD | -0.29% |
| 2006 Q3 | 500.65 Million CAD | 2.21% |
| 2006 FY | 1.74 Billion CAD | -11.48% |
| 2005 Q2 | 518.94 Million CAD | 6.33% |
| 2005 Q1 | 488.06 Million CAD | 14.57% |
| 2005 FY | 1.97 Billion CAD | 12.88% |
| 2005 Q3 | 487.79 Million CAD | -6.0% |
| 2005 Q4 | 490.45 Million CAD | 0.54% |
| 2004 Q1 | 429.57 Million CAD | -0.46% |
| 2004 Q4 | 425.98 Million CAD | -4.4% |
| 2004 Q3 | 445.6 Million CAD | -0.01% |
| 2004 FY | 1.74 Billion CAD | 1.29% |
| 2004 Q2 | 445.63 Million CAD | 3.74% |
| 2003 Q1 | 439.3 Million CAD | 0.0% |
| 2003 FY | 1.72 Billion CAD | -1.77% |
| 2003 Q3 | 433.05 Million CAD | 2.93% |
| 2003 Q4 | 431.54 Million CAD | -0.35% |
| 2003 Q2 | 420.71 Million CAD | -4.23% |
| 2002 FY | 1.75 Billion CAD | 3.0% |
| 2001 FY | 1.7 Billion CAD | -5.69% |
| 2000 FY | 1.8 Billion CAD | -4.51% |
| 1999 FY | 1.89 Billion CAD | -10.42% |
| 1998 FY | 2.11 Billion CAD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| The Amacore Group, Inc. | 28.82 Million USD | -4426.409% |
| Arem Pacific Corporation | 343.47 Thousand USD | -379823.372% |
| Assisted 4 Living, Inc. | 880.78 Thousand USD | -148058.909% |
| BioCorRx Inc. | 89.16 Thousand USD | -1463512.607% |
| Bionik Laboratories Corp. | 1.8 Million USD | -72188.697% |
| Banyan Corp. | 5 Million USD | -25979.893% |
| Clearday, Inc. | 12.48 Million USD | -10349.227% |
| Dental Patient Care America, Inc. | 3.24 Million USD | -40101.965% |
| Quantum Medical Transport, Inc. | 1310.14 USD | -99604293.424% |
| Empower Clinics Inc. | 4.66 Million USD | -27894.208% |
| First Choice Healthcare Solutions, Inc. | 29.98 Thousand USD | -4351932.683% |
| Selectis Health, Inc. | 36.78 Million USD | -3447.713% |
| Ethema Health Corporation | 5.34 Million USD | -24314.647% |
| HealthLynked Corp. | 5.72 Million USD | -22704.449% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 9.24 Million USD | -14009.498% |
| JRSIS Health Care Corporation | 3.46 Million USD | -37594.461% |
| Comjoyful International Company | - USD | -Infinity% |
| Medical Facilities Corporation | 453.75 Million USD | -187.592% |
| MedSmart Group Inc. | - USD | -Infinity% |
| North America Frac Sand, Inc. | 137.3 Thousand USD | -950307.487% |
| Nova Leap Health Corp. | 26.17 Million USD | -4884.743% |
| Nexteligent Holdings, Inc. | 351.66 Thousand USD | -370981.689% |
| PAO Group, Inc. | - USD | -Infinity% |
| Primemd Inc. | 10.5 Million USD | -12326.169% |
| Raffles Medical Group Ltd | 536.52 Million USD | -143.223% |
| Ryman Healthcare Limited | 650.53 Million USD | -100.598% |
| Stem Cell Authority, Ltd. | - USD | -Infinity% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 4.61 Million USD | -28185.22% |
| Mycotopia Therapies, Inc. | - USD | -Infinity% |
| U.S. NeuroSurgical Holdings, Inc. | - USD | -Infinity% |
| Veltex Corporation | 838.65 Thousand USD | -155501.356% |
| World Financial Holding Group | - USD | -Infinity% |
| Xcelerate Inc. | 1.12 Million USD | -116197.518% |